| EFX |
Report |
Total Revenue (Q2 2026) |
BEAT |
pred ~$1.720B vs. cons $1.699B (Visible Alpha, Jul 20, 2026) |
HIGH |
| EFX |
Report |
Adj. EPS Diluted Operating (Q2 2026) |
BEAT |
pred ~$2.28 vs. cons $2.21 (Visible Alpha / MarketBeat, Jul 20, 2026) |
HIGH |
| EFX |
Report |
EBITDA Margin % reported (Q2 2026) |
IN-LINE |
pred ~32.3% vs. cons 32.14% (Visible Alpha, Jul 20, 2026) |
MEDIUM |
| EFX |
Guide |
FY 2026 Revenue (FY 2026) |
BETTER |
guide ~$6.780-6.790B midpoint vs. cons $6.771B (Visible Alpha, Jul 20, 2026) |
MEDIUM |
| EFX |
Guide |
FY 2026 Adj. EPS (FY 2026) |
UNCHANGED |
guide ~$8.65-8.75 midpoint vs. cons $8.638 (Visible Alpha, Jul 20, 2026) [call: UNCHANGED to BETTER] |
MEDIUM |
| EFX |
Guide |
Q3 2026 Revenue (Q3 2026) |
UNKNOWN |
guide ~$1.720-1.750B vs. cons UNVERIFIED |
LOW |
| EFX |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
MEDIUM |
| EFX |
Return |
5-day cumulative residual |
-4.0% (FADE) |
FADE — sell-side models work through H2 implied cut; estimates drift lower over 5 days |
MEDIUM |